Breaking News
ERAS Stock Price | Erasca Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch
[ad_1]
Erasca Inc.
Erasca, Inc. is a clinical stage precision oncology company, It focuses on discovering, developing, and commercializing therapies for RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim on July 2, 2018 and is headquartered in San Diego, CA.
[ad_2]
